FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39911000001101: Oxybutynin 5mg tablets (Alpharma Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17144701000001113 Oxybutynin 5mg tablets (Alpharma Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37700501000001110 Oxybutynin 5mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 5mg tablets (Alpharma Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Is a Product containing precisely oxybutynin hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxybutynin 5mg tablets (Alpharma Limited) 56 tablet 4 x 14 tablets Is pack of False Oxybutynin 5mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Alpharma Limited) 56 tablet 4 x 14 tablets Has AMP True Oxybutynin 5mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Actavis UK Ltd) 84 tablet 6 x 14 tablets Has AMP True Oxybutynin 5mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start